Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Peripheral Blood Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00509691
What this trial is testing

Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy

Who this might be right for
Cancer
University of Louisville 20
Very early researchStudy completedNCT01836068
What this trial is testing

Optimized Antiretroviral Therapy During Allogeneic Hematopoietic Stem Cell Transplantation in HIV-1 Individuals

Who this might be right for
HIV
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT00061568
What this trial is testing

Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias

Who this might be right for
Congenital Hemolytic AnemiaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 130
Large-scale testing (Phase 3)Study completedNCT00003816
What this trial is testing

Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more
Roswell Park Cancer Institute 361
Testing effectiveness (Phase 2)Study completedNCT00006252
What this trial is testing

Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Cancer and Leukemia Group B 47
Testing effectiveness (Phase 2)Study completedNCT01509560
What this trial is testing

PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood

Who this might be right for
Condition After Allogenic Peripheral Stem Cell Transplantation (SCT)
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH 21
Testing effectiveness (Phase 2)Ended earlyNCT00074269
What this trial is testing

Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer

Who this might be right for
Breast Cancer
University of California, San Diego 5
Testing effectiveness (Phase 2)Ended earlyNCT04205240
What this trial is testing

Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

Who this might be right for
Recurrent Plasma Cell Myeloma
Srinivas Devarakonda 1
Testing effectiveness (Phase 2)Study completedNCT00045435
What this trial is testing

Reduced Intensity Donor Peripheral Blood Stem Cell Transplant in Treating Patients With De Novo or Secondary Acute Myeloid Leukemia in Remission

Who this might be right for
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic SyndromeAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+14 more
Fred Hutchinson Cancer Center 17
Not applicableStudy completedNCT00534118
What this trial is testing

Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Roswell Park Cancer Institute 39
Large-scale testing (Phase 3)Study completedNCT01020175
What this trial is testing

Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation

Who this might be right for
Acute LeukemiaChronic Myelogenous LeukemiaMyelodysplastic Syndrome
European Society for Blood and Marrow Transplantation 350
Testing effectiveness (Phase 2)Study completedNCT00047060
What this trial is testing

Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome

Who this might be right for
Mycosis FungoidesSezary Syndrome
National Heart, Lung, and Blood Institute (NHLBI) 5
Early research (Phase 1)WithdrawnNCT03531281
What this trial is testing

Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHematopoietic Cell Transplantation Recipient
City of Hope Medical Center
Large-scale testing (Phase 3)UnknownNCT03295058
What this trial is testing

Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients

Who this might be right for
Severe Aplastic Anemia
Assiut University 50
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Not applicableNo Longer AvailableNCT03010332
What this trial is testing

Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease

Who this might be right for
CMV ViremiaCMV Disease
Atara Biotherapeutics
Testing effectiveness (Phase 2)Study completedNCT02743351
What this trial is testing

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia+3 more
Fate Therapeutics 96
Testing effectiveness (Phase 2)Looking for participantsNCT07249346
What this trial is testing

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

Who this might be right for
LeukemiaMyelodysplasiaChronic Myelomonocytic Leukemia
Hannah Choe, MD 124
Testing effectiveness (Phase 2)Study completedNCT00116441
What this trial is testing

Vaccination in the Peripheral Stem Cell Transplant Setting for Multiple Myeloma

Who this might be right for
Multiple Myeloma
Cell Genesys 22
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Next Page